23 June 2022
FD Technologies plc
("FD Technologies" or the "Company")
Issue of Equity
FD Technologies (AIM: FDP.L, Euronext Growth: FDP.I) announces that on 23 June 2022 the Company allotted 94,000 new ordinary shares of £0.005 each in the Company ("the Ordinary Shares") pursuant to the exercise of share options by certain employees.
Application has been made for the new Ordinary Shares to be admitted to trading on AIM and Euronext Growth and it is expected that admission will take place on 29 June 2022. The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following these allotments, the total issued share capital of the Company will increase to 27,952,354 ordinary shares.
Enquiries
For further information please contact:
|
FD Technologies plc Seamus Keating, Chief Executive Officer Ryan Preston, Chief Financial Officer Ian Mitchell, Head of Investor Relations |
+44 (0) 28 3025 2242 |
|
|
|
|
Investec Bank plc (Nominated Adviser and Broker) Andrew Pinder Carlton Nelson Virginia Bull |
+44 (0) 20 7597 5970 |
|
|
|
|
Goodbody (Euronext Growth Adviser and Broker) David Kearney Don Harrington Finbarr Griffin |
+353 1 667 0420 |
|
|
|
|
J.P. Morgan Cazenove (Broker) James A. Kelly Mose Adigun
|
+44 (0) 20 7742 4000 |
About FD Technologies
FD Technologies is a group of data-driven businesses that unlock the value of insight, hindsight and foresight to drive organisations forward. The Group comprises KX, the leading technology for real-time continuous intelligence; First Derivative, which provides technology-led services in capital markets; and MRP, the only enterprise-class, predictive Accounts Based Marketing solution. FD Technologies operates from 12 offices across Europe, North America and Asia Pacific, and employs more than 3,000 people worldwide.
For further information, please visit www.fdtechnologies.com and www.kx.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
